Background The COVID-19 pandemic has highlighted health disparities affecting ethnic
minority communities. There is growing concern about the lack of diversity in clinical trials …

Dementia is a leading global public health challenge. Prevention approaches have
traditionally focused on individual‐level strategies. However, such approaches have limited …

Background The timely detection of Alzheimer's disease and other related dementias
(ADRD) is suboptimal. Digital data already stored in electronic health records (EHR) offer …

Dementia is often undiagnosed in primary care, and even when diagnosed, untreated. The 5-
Cog paradigm, a brief, culturally adept, cognitive detection tool paired with a clinical …

Background To address the rising prevalence of Alzheimer's disease and related dementias,
effective interventions that can be widely disseminated are warranted. The Preventing …

Background Inclusion of ethnic/racial minorities in clinical trials is essential to fully assess
therapeutic efficacy. It is well-known that populations respond dissimilarly to interventions …

Introduction Acculturation‐related characteristics, that is, factors directly connected to culture
and familial relationships, are associated with engaged research participation within Latino …

Background Recruitment to dementia prevention clinical trials is challenging, and
participants are not representative of US adults at risk. A better understanding of the general …

Objectives The increasing heterogeneity of the population of older people is reflected in an
increasing number of people with dementia and carers drawn from minority ethnic groups …

Background Goals‐of‐care discussions (GOCD) are uncommon in persons living with
dementia (PLWD) despite the likelihood of eventual loss of decisional capacity in the …